1. Home
  2. XXII vs ENVB Comparison

XXII vs ENVB Comparison

Compare XXII & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$2.54

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

HOLD

Current Price

$1.95

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XXII
ENVB
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.0M
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
XXII
ENVB
Price
$2.54
$1.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.4K
36.5K
Earning Date
03-26-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
69.96
N/A
EPS
N/A
N/A
Revenue
$25,832,530.00
$39,914,675.00
Revenue This Year
N/A
N/A
Revenue Next Year
$79.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$0.56
52 Week High
$11.37
$13.25

Technical Indicators

Market Signals
Indicator
XXII
ENVB
Relative Strength Index (RSI) 26.64 35.70
Support Level $2.18 $1.11
Resistance Level $2.67 $2.06
Average True Range (ATR) 0.26 0.09
MACD -0.11 0.04
Stochastic Oscillator 0.00 13.64

Price Performance

Historical Comparison
XXII
ENVB

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: